PULMOTIL G100 PREMIX FOR MEDICATED FEEDINGSTUFF
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
27-04-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
TILMICOSIN
Available from:
Elanco Animal Health, Eli Lilly and Company Limited
ATC code:
QJ01FA91
INN (International Name):
TILMICOSIN
Dosage:
100
Pharmaceutical form:
Premix for Med.Feedstuffs
Prescription type:
POM
Therapeutic group:
Porcine
Therapeutic area:
Tilmicosin
Therapeutic indications:
Antibacterial
Authorization status:
Authorised
Authorization date:
1997-01-24
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Pulmotil G100 Premix for medicated feedingstuff
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Premix for medicated feedingstuff. A yellowish tan to reddish tan free flowing granular material.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs and rabbits
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Pigs: Prevention and treatment of respiratory disease caused by _Actinobacillus pleuropneumoniae, Mycoplasma_
_hyopneumoniae, Pasteurella multocida _and other organisms sensitive to tilmicosin.
Rabbits: Prevention and treatment of respiratory disease caused by _Pasteurella multocida _and _Bordetella_
_bronchiseptica, _susceptible to tilmicosin.
4.3 CONTRAINDICATIONS
Horses or other E_quidae_, must not be allowed access to feeds containing tilmicosin. Horses fed with tilmicosin medicated
feeds may present signs of toxicity with lethargy, anorexia, reduction of feed consumption, loose stools, colic, distension of
the abdomen and death.
Do not use in case of hypersensitivity to tilmicosin or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Under practical conditions, the management of respiratory disease outbreaks recognises that acutely ill animals are inappetant and
require parenteral therapy.
ACTIVE SUBSTANCE:
Tilmicosin (as phosphate)
100 g/kg
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 28/11/2013_
_CRN 7016168_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Inappropriate use of the product may increase the prevalence of bacteria resistant to tilmicosin and may decrease the
effectiveness of treatment wit
Read the complete document
